J Gynecol Oncol.  2016 Jul;27(4):e36. 10.3802/jgo.2016.27.e36.

Position statements on genetic test for peritoneal, ovarian, and fallopian tubal cancers: Korean Society of Gynecologic Oncology (KSGO)

Affiliations
  • 1Comprehensive Gynecologic Cancer Center, Department of Obstetrics and Gynecology, CHA Bundang Medical Center, CHA University, Seongnam, Korea.
  • 2Center for Uterine Cancer, National Cancer Center, Goyang, Korea. gynlim@gmail.com
  • 3Department of Obstetrics and Gynecology, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea.
  • 4Department of Obstetrics and Gynecology, Pusan National University Yangsan Hospital, Pusan National University School of Medicine, Yangsan, Korea.
  • 5Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • 6Department of Obstetrics and Gynecology, Ajou University School of Medicine, Suwon, Korea.
  • 7Department of Obstetrics and Gynecology, Seoul National University College of Medicine, Seoul, Korea.

Abstract

No abstract available.


MeSH Terms

Fallopian Tube Neoplasms/*genetics
Female
Genes, BRCA1
Genes, BRCA2
*Genetic Testing
Humans
Mutation
Ovarian Neoplasms/*genetics
Peritoneal Neoplasms/*genetics
Republic of Korea
Societies, Medical
Full Text Links
  • JGO
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr